Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion

Pharmaceutical Research

Volumn 14, Issue 9, 1997, Pages 1133-1139

  Graumlich, James F ^a   Ludden, Thomas M ^b   Conry Cantilena, Cathy ^c   Cantilena Jr , Louis R ^d   Wang, Yaohui ^e   Levine, Mark ^e,f  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^f Intramural Nutrition Program

Author keywords

Ascorbic acid; Ascorbic acid deficiency; Bioavailability; Human; Models nonlinear; Models theoretical; Pharmacokinetics

Indexed keywords

ASCORBIC ACID;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DISTRIBUTION; HUMAN; HUMAN EXPERIMENT; KIDNEY TUBULE ABSORPTION; MALE; MODEL; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; VOLUNTEER;

EID: 0030765538     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012186203165     Document Type: Article

References (28)

1. J. Blanchard, K. A. Conrad, R. A. Mead, and P. J. Garry. Am. J. Clin. Nutr. 51:837-845 (1990).
2. S. Yung, M. Mayersohn, and J. B. Robinson. J. Pharm. Sci. 67:1491-1492 (1978).
3. G. Zetler, G. Seidel, C. P. Siegers, and H. Iven. Eur. J. Clin. Pharmacol. 10:273-282 (1976).
4. A. Kallner, D. Hartmann, and D. Hornig. Am. J. Clin. Nutr. 32:530-539 (1979).
5. S. Melethil, M. B. Subrahmanyam, C. J. Chang, and W. D. Mason. Ann. NY Acad. Sci. 498:491-493 (1987).
6. V. K. Piotrovskij, Z. Kallay, M. Gajdos, M. Gerykova, and T. Trnovec. Biopharm. Drug. Dispos. 14:429-442 (1993).
7. M. Mayersohn. Eur. J. Pharmacol. 19:140-142 (1972).
8. S. Melethil, W. D. Mason, and C. J. Chang. Internat. J. Pharmaceu. 31:83-89 (1986).
9. P. W. Washko, D. Rotrosen, and M. Levine. J. Biol. Chem. 264:18996-19002 (1989).
10. P. Bergsten, G. Amitai, J. Kehrl, K. R. Dhariwal, H. G. Klein, and M. Levine. J. Biol. Chem. 265:2584-2587 (1990).
11. R. W. Welch, P. Bergsten, J. D. Butler, and M. Levine. Biochem. J. 294:505-510 (1993).
12. P. Bergsten, R. Yu, J. Kehrl, and M. Levine. Arch. Biochem. Biophys. 317:208-214 (1995).
13. E. P. Ralli, G. J. Friedman, and S. H. Rubin. J. Clin. Invest. 17:765-770 (1938).
14. M. Levine, C. Conry-Cantilena, Y. Wang, R. W. Welch, P. W. Washko, K. R. Dhariwal, J. B. Park, A. Lazarev, J. F. Graumlich, J. King, and L. R. Cantilena. Proc. Natl. Acad. Sci. USA 93:3704-3709 (1996).
15. J. King, R. W. Welch, Y. Wang, K. R. Dhariwal, C. Conry-Cantilena, and M. Levine. Am. J. Clin. Nutr. (1997) in press.
16. M. Levine, K. R. Dhariwal, and C. C. Cantilena. World Rev. Nutr. Dietetics 72:114-127 (1993).
17. K. R. Dhariwal, W. O. Hartzell, and M. Levine. Am. J. Clin. Nutr. 54:712-716 (1991).
18. E. M. Baker, R. E. Hodges, J. Hood, H. E. Sauberlich, S. C. March, and J. E. Canham. Am. J. Clin. Nutr. 24:444-454 (1971).
19. L. Berger, C. D. Gerson, and T. F. Yu. Am. J. Med. 62:71-76 (1977).
20. S. L. Beal, and L. B. Sheiner. NONMEM User's Guide Pans I-VI, NONMEM Project Group, Division of Clinical Pharmacology, University of California, San Francisco, 1992.
21. M. Rowland and T. N. Tozer. Clinical Pharmacokinetics Concepts and Applications, 3rd ed., Williams & Wilkins, Baltimore 1995.
22. S. Kleit, D. Levin, T. Perenich, and R. Cade. Am. J. Physiol. 209:195-198 (1965).
23. P. W. Washko, Y. Wang, and M. Levine. J. Biol. Chem. 268:15531-15535 (1993).
24. D. Hornig. Ann. NY Acad. Sci. 258:103-118 (1975).
25. th ed., National Academy Press, Washington, DC, 1989.
26. th ed., National Academy of Sciences, Washington, DC, 1980, pp. 72-81.
27. Food and Nutrition Board. How should the Recommended Dietary Allowances be Revised, National Academy Press, Washington, DC 1994.
28. th ed., International Life Sciences Institute, Washington, DC, 1996, pp. 146-159.